6:17 Minutes ASTCT 2023 Guidelines: Prevention of CMV infection and disease after HCT ASTCT 2023 Guidelines: Prevention of CMV infection and disease after HCT BACK TO WEBCASTS MY-CYT-00108 June/2022
52:19 Minutes - 2 Chapters 1L Advanced Esophageal Cancer: Entering a New Survival Horizon BACK TO WEBCASTS MY-PDO-00044 Oct/2022
52:19 Minutes - 1 Chapter Thor’s Hammer: Is it worthy against Covid-19? Thor's Hammer: Is it worthy against Covid-19? BACK TO WEBCASTS MY-LAG-00063 Sep/2022
66:18 Minutes - 4 Chapters Unlocking New Paradigm in the Treatment of Metastatic TNBC BACK TO WEBCASTS MY-OBR-00021 Apr/2022
39 Minutes - 3 Chapters Personalizing Treatment of M/uR HNSCC with Immune Checkpoint Inhibitor BACK TO WEBCASTS MY-OHN-00015 Apr/2022
35:00 Minutes - 3 Chapters Redefining Survival Expectation for Relapsed or Refractory Classical Hodgkin Lymphoma
37:52 Changing Paradigm in Management of CMV Changing Paradigm in Management of CMV MY-CYT-00088 Mar/2022
51 Minutes - 3 Chapters Evidence of Immune Checkpoint Blockade with Pembrolizumab for R/R cHL BACK TO WEBCASTS MY-KEY-00364 Oct/2020
39 Minutes - 1 Chapter Update on the latest evidence PPC Overview In case you missed the latest update on Post-Operative Pulmonary Complications feel free to catch up at your convenience […]
47 Minutes - 1 Chapter ERAS implementation and sustainability Overview In case you missed the latest update on Post-Operative Pulmonary Complications feel free to catch up at your convenience […]
49 Seconds - 1 Chapter Heartfelt Thanks to All Healthcare Professionals from MSD Overview On behalf of all the employees in MSD, we are sending out our sincere and heartfelt thanks and appreciation […]
7 Minutes - 1 Chapter Visualizing Clinical Inertia in Type 2 Diabetes Overview TEarly bird gets the worm? Let’s hear from Professor Mikael Ryden from Karolinska University Hospital in Stockholm, Sweden talk […]